IRIS UniCatt

Fresa, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 575
EU - Europa 532
AS - Asia 439
SA - Sud America 94
AF - Africa 7
OC - Oceania 1
Totale 1.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 559
IT - Italia 180
SG - Singapore 164
CN - Cina 121
BR - Brasile 82
DE - Germania 82
SE - Svezia 75
IN - India 61
FR - Francia 50
ID - Indonesia 32
IE - Irlanda 31
KR - Corea 30
FI - Finlandia 28
RU - Federazione Russa 18
GB - Regno Unito 13
AT - Austria 12
CA - Canada 12
CZ - Repubblica Ceca 10
NL - Olanda 7
TR - Turchia 6
ES - Italia 5
HK - Hong Kong 5
BE - Belgio 4
CO - Colombia 4
IR - Iran 3
MX - Messico 3
PL - Polonia 3
AZ - Azerbaigian 2
BD - Bangladesh 2
BO - Bolivia 2
CI - Costa d'Avorio 2
IL - Israele 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
UA - Ucraina 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
EC - Ecuador 1
EE - Estonia 1
GA - Gabon 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.648
Salva come PNG Salva come JPEG
Città #
Singapore 131
Chandler 80
Ashburn 53
Hyderabad 53
Rome 49
Chicago 36
Florence 36
Jakarta 32
Dublin 31
Seoul 30
New York 29
Milan 28
Hefei 27
Frankfurt am Main 26
Los Angeles 25
Munich 14
Nuremberg 14
Moscow 13
Tampa 12
Turku 12
Bremen 11
Princeton 11
Boston 10
Salt Lake City 10
Beijing 9
Buffalo 9
Düsseldorf 9
Helsinki 9
Vienna 9
Wilmington 9
San Mateo 8
Elk Grove Village 7
Lappeenranta 7
Marseille 7
The Dalles 7
Brno 6
Lauterbourg 6
London 6
Washington 6
North Hollywood 5
Pavia 5
Rio de Janeiro 5
Santa Clara 5
Toronto 5
Brdo 4
Brussels 4
Council Bluffs 4
Dallas 4
Dulles 4
Turin 4
Amsterdam 3
Ankara 3
Arezzo 3
Atlanta 3
Belo Horizonte 3
Bogotá 3
Central 3
Fairfield 3
Ottawa 3
Paris 3
Portsmouth 3
San Francisco 3
San Marzano sul Sarno 3
Seville 3
São Paulo 3
Abidjan 2
Afragola 2
Bangalore 2
Brooklyn 2
Campo Grande 2
Cattolica 2
Colombo 2
Curitiba 2
Gdansk 2
Guangzhou 2
Hong Kong 2
Kansas City 2
La Paz 2
Lancaster 2
Livorno 2
Manaus 2
Matera 2
Miami 2
Michigan City 2
Montreal 2
Naples 2
Napoli 2
Newark 2
Phoenix 2
Piracicaba 2
Porto Alegre 2
Pune 2
Redwood City 2
Shanghai 2
Sinop 2
Stockholm 2
Tunis 2
Vigo 2
Woodbridge 2
Zanjan 2
Totale 1.051
Salva come PNG Salva come JPEG
Nome #
Role of microRNAs in Chronic Lymphocytic Leukemia 118
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 93
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 83
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 78
the concomitance of lymphoma and breast carcinoma in the bone 74
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 66
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 60
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 59
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 54
The concomitance of lymphoma and breast carcinoma in the bone 54
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 54
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 52
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 51
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 49
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 47
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 44
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 44
Richter transformation in Chronic Lymphocytic Leukemia 43
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 43
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 43
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 42
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 39
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 38
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 38
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 36
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 36
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 34
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study 32
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 31
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 30
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 29
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study 25
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 22
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 14
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 12
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 10
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 9
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed 8
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature 7
CAR-T Cells in Chronic Lymphocytic Leukemia 6
Totale 1.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.148
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/20218 0 0 0 0 1 0 2 0 2 0 3 0
2021/202282 0 3 3 2 7 0 1 9 5 0 34 18
2022/2023290 34 34 13 31 25 25 12 20 45 17 31 3
2023/2024363 6 64 22 37 15 55 31 21 2 26 31 53
2024/2025947 21 19 57 55 65 39 44 27 93 122 373 32
Totale 1.707